Allarity Therapeutics Stock Forward View - Simple Exponential Smoothing
| ALLR Stock | USD 1.26 -0.02 -1.56% |
Predicting where Allarity Therapeutics' stock will trade is more achievable when sentiment data complements traditional analysis. This module isolates the sentiment-driven component of price to highlight potential mispricings.
At this point in time, the 14-period RSI for Allarity Therapeutics is 0, signaling extreme oversold conditions. Historically, RSI levels this depressed have preceded relief bounces, though the magnitude and duration vary widely.Momentum
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter -0.21 | EPS Estimate Current Year -0.85 | EPS Estimate Next Year -0.91 | Wall Street Target Price 9.25 |
This view frames how Allarity Therapeutics responds to recent headlines and peer activity within its market context.
The Simple Exponential Smoothing forecasted value of Allarity Therapeutics on the next trading day is expected to be 1.26 with a mean absolute deviation of 0.04 and the sum of the absolute errors of 2.42.Allarity Therapeutics after-hype prediction price | $ 1.26 |
This view adds attention context to forecasting, technical signals, analyst estimates, and earnings data.
Allarity | Build portfolio with Allarity Stock |
Allarity Therapeutics Additional Predictive Modules
Predictive models for Allarity Therapeutics combine technical indicators with statistical methods to estimate probable price trajectories. Ensemble techniques that blend multiple model outputs often produce more stable predictions than any single model.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Simple Exponential Smoothing Price Forecast For the 18th of March 2026
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Allarity Therapeutics on the next trading day is expected to be 1.26 with a mean absolute deviation of 0.04 , mean absolute percentage error of 0.0032 , and the sum of the absolute errors of 2.42 .Please note that although there have been many attempts to predict Allarity Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Allarity Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stock Forecast Pattern
| Backtest Allarity Therapeutics | Allarity Therapeutics Price Prediction | Research Analysis |
Forecasted Value
The next-day forecast for Allarity Therapeutics focuses on identifying predictive downside and upside bands that can frame a realistic trading range. The projected forecast band currently runs from roughly 0.01 on the downside to about 6.80 on the upside.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Allarity Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Allarity Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 110.5291 |
| Bias | Arithmetic mean of the errors | -0.004 |
| MAD | Mean absolute deviation | 0.0403 |
| MAPE | Mean absolute percentage error | 0.0382 |
| SAE | Sum of the absolute errors | 2.42 |
The mean reversion effect in Allarity Therapeutics is stronger when the initial deviation was driven by sentiment rather than fundamental change. Identifying the root cause of Allarity Therapeutics' price dislocation is essential before acting.
After-Hype Price Density Analysis
The probability distribution for Allarity Therapeutics' predicted price encodes the full spectrum of outcomes, weighted by their estimated likelihood. Investors should compare this range against their personal risk tolerance before committing to Allarity Therapeutics positions.
Next price density |
| Expected price to next headline |
Estimiated After-Hype Price Volatility
The news prediction model for Allarity Therapeutics analyzes the correlation between Allarity Therapeutics' historical headline events and same-day or next-day price movements. Allarity Therapeutics' after-hype downside and upside margins for the prediction period are 0.06 and 6.80, respectively. Predictive accuracy varies significantly across different news categories and market regimes for Allarity Therapeutics.
Current Value
The next after-hype price estimate for Allarity Therapeutics is modeled on a 3 months horizon and is intended to show how price could normalize after sentiment pressure fades. Used correctly, the estimate adds context around potential normalization rather than promising a specific realized outcome.
Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Allarity Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Allarity Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Allarity Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.53 | 5.54 | 0.03 | 0.01 | 7 Events | 7 Events | In 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.26 | 1.26 | 2.33 |
|
Hype Timeline
Allarity Therapeutics is presently traded for 1.26. The company has historical hype elasticity of -0.03, and average elasticity to hype of competition of -0.01. Allarity is expected to decline in value after the next headline, with the price expected to drop to 1.26. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -2.33%, whereas the daily expected return is presently at 0.53%. The volatility of related hype on Allarity Therapeutics is about 23083.33%, with the expected price after the next announcement by competition of 1.25. The company has price-to-book (P/B) ratio of 1.68. Some equities with similar Price to Book (P/B) outperform the market in the long run. Allarity Therapeutics recorded earnings per share (EPS) of 5.75. The company had not issued any dividends in recent years. The firm completed a 1:30 stock split on 11th of September 2024. Given the investment horizon of 90 days the next expected press release will be in 7 days. Historical Fundamental Analysis of Allarity Therapeutics provides a cross-check on projections for Allarity Therapeutics. The analysis adds historical context for the projection set.Related Hype Analysis
Sector-wide news events often affect Allarity Therapeutics before the fundamental impact on Allarity Therapeutics' own business becomes clear. Peer hype analysis helps investors distinguish between sector-level sentiment shifts and Allarity Therapeutics-specific developments.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CING | Cingulate | -0.13 | 7 per month | 3.82 | 0.28 | 14.89 | -6.53 | 24.88 | |
| PCSA | Processa Pharmaceuticals | -0.22 | 7 per month | 0.00 | -0.0026 | 10.24 | -14.08 | 164.28 | |
| BCTX | Briacell Therapeutics Corp | -0.09 | 7 per month | 0.00 | -0.09 | 7.66 | -8.84 | 98.43 | |
| LEXX | Lexaria Bioscience Corp | 0.02 | 9 per month | 0.00 | -0.05 | 10.61 | -12.05 | 42.53 | |
| ENTO | Entero Therapeutics | -0.23 | 6 per month | 0.00 | -0.01 | 16.86 | -17.06 | 39.61 | |
| LIXT | Lixte Biotechnology Holdings | -0.04 | 7 per month | 0.00 | -0.06 | 10.20 | -6.85 | 24.63 | |
| CLSD | Clearside Biomedical | 0.36 | 6 per month | 0.00 | -0.27 | 7.96 | -17.54 | 83.67 | |
| KAPA | Kairos Pharma | 0.04 | 33 per month | 0.00 | -0.07 | 10.26 | -8.24 | 29.57 | |
| CRIS | Curis Inc | 0.01 | 8 per month | 0.00 | -0.11 | 6.48 | -8.33 | 21.52 | |
| CASI | CASI Pharmaceuticals | 0.04 | 8 per month | 0.00 | -0.12 | 11.90 | -8.51 | 98.17 |
Other Forecasting Options for Allarity Therapeutics
For both new and experienced investors in Allarity, the ability to analyze Allarity Therapeutics' price movement is a fundamental investment skill. Price chart noise in Allarity Stock can create false signals and mislead investment decisions.Allarity Therapeutics Related Equities
The following equities are related to Allarity Therapeutics within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Allarity Therapeutics against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Allarity Therapeutics Market Strength Events
Tracking market strength indicators for Allarity Therapeutics helps investors understand the momentum dynamics of the stock in real time. These signals support informed decisions about when to enter or exit positions in Allarity Therapeutics for maximum return potential.
Allarity Therapeutics Risk Indicators
Properly assessing Allarity Therapeutics' risk indicators is a prerequisite for building reliable price forecasts. Identifying and quantifying the risks associated with Allarity Therapeutics' allows investors to make better-informed decisions about accepting or hedging their exposure.
| Mean Deviation | 3.84 | |||
| Semi Deviation | 4.14 | |||
| Standard Deviation | 5.45 | |||
| Variance | 29.72 | |||
| Downside Variance | 22.27 | |||
| Semi Variance | 17.13 | |||
| Expected Short fall | -4.85 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Allarity Therapeutics
A coverage review of Allarity Therapeutics helps investors see when the security is attracting above-average attention from contributors and market observers. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Contributor Headline
Latest Perspective From Macroaxis
Allarity Therapeutics Short Properties
A short-interest review of Allarity Therapeutics helps investors understand whether skepticism in the market is becoming more influential. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 1.6 M | |
| Cash And Short Term Investments | 19.5 M |
Additional Tools for Allarity Stock Analysis
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Holdings Check your current holdings and cash position to determine if your portfolio needs rebalancing | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |